Fear Mongering At The FDA
I haven’t seen the preliminary Naproxyn data that the FDA based its press release on, but this article suggests that the increase in cardiac events wasn’t even statistically significant:
In the Alzheimer’s study, though, there was no increase in heart risk for long-term Celebrex users. There was a slight increase in heart risk for naproxen users, but the increase was so small that it may have been a chance occurrence. It was not the kind of data on which decisions involving many thousands of patients should have been made.
